DCF — MEDSTAR MONTGOMERY MEDICAL CENTER
Enterprise Value: $-374.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-374.3M
Enterprise Value
$-116.6M
PV of Cash Flows
$-257.7M
PV of Terminal Value
$-415.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $178.9M | $-24.3M | -14.0% | $-31.9M | $-29.0M |
| Year 2 | $184.3M | $-23.2M | -13.0% | $-31.0M | $-25.6M |
| Year 3 | $189.8M | $-22.0M | -12.0% | $-30.1M | $-22.6M |
| Year 4 | $195.5M | $-21.7M | -11.0% | $-30.0M | $-20.5M |
| Year 5 | $201.4M | $-21.8M | -11.0% | $-30.4M | $-18.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-374.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$173.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14098493015451932
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5